✦ LIBER ✦

ChemInform Abstract: Discovery of S-444823, a Potent CB1/CB2 Dual Agonist as an Antipruritic Agent.

✍ Scribed by Masahide Odan; et al. et al.

Book ID: 112049312
Publisher: John Wiley and Sons
Year: 2012
Weight: 22 KB
Volume: 43
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.201235180

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery of S-444823, a potent CB1/CB2

Discovery of S-444823, a potent CB1/CB2 dual agonist as an antipruritic agent

✍ Masahide Odan; Natsuki Ishizuka; Yoshiharu Hiramatsu; Masanao Inagaki; Hiroshi H 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 719 KB

ChemInform Abstract: Discovery of S-7774

ChemInform Abstract: Discovery of S-777469: An Orally Available CB2 Agonist as an Antipruritic Agent.

✍ Masahide Odan; et al. et al. 📂 Article 📅 2012 🏛 John Wiley and Sons ⚖ 27 KB

ChemInform Abstract: Design, Synthesis a

ChemInform Abstract: Design, Synthesis and Structure—Activity Relationships of (Indo-3-yl) Heterocyclic Derivatives as Agonists of the CB1 Receptor. Discovery of a Clinical Candidate.

✍ Paul Ratcliffe; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 21 KB

ChemInform Abstract: Structure-Activity

ChemInform Abstract: Structure-Activity Relationships of a Series of Substituted Benzamides: Potent D2/5-HT2 Antagonists and 5-HT1a Agonists as Neuroleptic Agents.

✍ M. H. NORMAN; G. C. RIGDON; W. R. HALL; F. III NAVAS 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 30 KB

ChemInform Abstract: Discovery of a Pote

ChemInform Abstract: Discovery of a Potent and Orally Available Acyl-CoA: Cholesterol Acyltransferase Inhibitor as an Antiatherosclerotic Agent: (4-Phenylcoumarin)acetanilide Derivatives.

✍ Masaki Ogino; et al. et al. 📂 Article 📅 2012 🏛 John Wiley and Sons ⚖ 21 KB 👁 1 views

## Abstract Structure‐activity relationship studies lead to the discovery of compound (I), which shows potent ACAT inhibitory activity (IC~50~ = 12 nM) and good pharmacokinetic profile in mice.

ChemInform Abstract: Discovery of the Im

ChemInform Abstract: Discovery of the Imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepine Scaffold as a Novel, Potent and Selective GABAA α5 Inverse Agonist Series.

✍ Andrew W. Thomas; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 23 KB 👁 1 views